157 related articles for article (PubMed ID: 12460411)
1. A case of nephrotic syndrome due to lupus nephritis which was controlled with low-density lipoprotein apheresis.
Kamijo Y; Kaneko Y; Ichikawa T; Kobayashi N; Koyama T; Kakegawa T; Kamijo H; Kono K; Minami S; Tanaka N; Arakura H; Hirata M; Higuchi M; Kiyosawa K; Hora K
Ther Apher; 2002 Dec; 6(6):459-62. PubMed ID: 12460411
[TBL] [Abstract][Full Text] [Related]
2. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
Miyazono M; Tomiyoshi Y; Kishi T; Ikeda Y; Sakemi T; Sanai T; Node K
Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein apheresis for proteinuria in lupus nephritis with intraglomerular foam cells containing cholesterol crystals.
Shiraishi N; Kitamura K; Hayata M; Ogata T; Tajiri-Okamura K; Nakayama Y; Kohda Y; Tomita K; Mukoyama M
Am J Kidney Dis; 2015 Mar; 65(3):490-3. PubMed ID: 25542412
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis.
Kawasaki Y; Suzuki S; Matsumoto A; Takano K; Suyama K; Hashimoto K; Suzuki J; Suzuki H; Hosoya M
Pediatr Nephrol; 2007 Jun; 22(6):889-92. PubMed ID: 17277952
[TBL] [Abstract][Full Text] [Related]
5. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group.
Muso E; Mune M; Fujii Y; Imai E; Ueda N; Hatta K; Imada A; Miki S; Kuwahara T; Takamitsu Y; Takemura T; Tsubakihara Y
Kidney Int Suppl; 1999 Jul; 71():S122-5. PubMed ID: 10412754
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis.
Oto J; Suga K; Matsuura S; Kondo S; Ohnishi Y; Inui D; Imanaka H; Kagami S; Nishimura M
J Anesth; 2009; 23(2):284-7. PubMed ID: 19444573
[TBL] [Abstract][Full Text] [Related]
7. An update on LDL apheresis for nephrotic syndrome.
Raina R; Krishnappa V
Pediatr Nephrol; 2019 Oct; 34(10):1655-1669. PubMed ID: 30218191
[TBL] [Abstract][Full Text] [Related]
8. Focal Segmental Glomerular Sclerosis Ameliorated by Long-term Hemodialysis Therapy with Low-density Lipoprotein Apheresis.
Araki H; Ono S; Nishizawa Y; Deji N; Nakazawa J; Morita Y; Kume S; Chin-Kanasaki M; Isshiki K; Araki S; Arimura T; Maegawa H; Uzu T
Intern Med; 2015; 54(17):2213-7. PubMed ID: 26328649
[TBL] [Abstract][Full Text] [Related]
9. Dextran sulphate cellulose columns for the treatment of nephrotic syndrome due to inactive lupus nephritis.
Daimon S; Saga T; Nakayama M; Nomura Y; Chikaki H; Dan K; Koni I
Nephrol Dial Transplant; 2000 Feb; 15(2):235-8. PubMed ID: 10648671
[No Abstract] [Full Text] [Related]
10. [Excellent antiproteinuric effect by LDL apheresis in a case with severe renal dysfunction due to focal segmental glomerulosclerosis].
Iwahori T; Yoshida M; Sugiura M; Ioya N; Kawaguchi M
Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):91-7. PubMed ID: 8717311
[TBL] [Abstract][Full Text] [Related]
11. Umbilical Cord Blood Transplantation-associated Nephrotic Syndrome Successfully Treated by Low-density Lipoprotein Apheresis.
Sugawara Y; Honda K; Katagiri D; Nakamura M; Kawakami T; Nasu R; Hayashi A; Shintani Y; Tojo A; Noiri E; Kurokawa M; Fukayama M; Nangaku M
Intern Med; 2016; 55(19):2831-2836. PubMed ID: 27725544
[TBL] [Abstract][Full Text] [Related]
12. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
[TBL] [Abstract][Full Text] [Related]
13. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.
Hattori M; Chikamoto H; Akioka Y; Nakakura H; Ogino D; Matsunaga A; Fukazawa A; Miyakawa S; Khono M; Kawaguchi H; Ito K
Am J Kidney Dis; 2003 Dec; 42(6):1121-30. PubMed ID: 14655182
[TBL] [Abstract][Full Text] [Related]
14. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome.
Sakurai M; Muso E; Matushima H; Ono T; Sasayama S
Kidney Int Suppl; 1999 Jul; 71():S210-2. PubMed ID: 10412778
[TBL] [Abstract][Full Text] [Related]
15. Remission of a refractory nephrotic syndrome after low-density lipoprotein apheresis based on dextrane sulphate adsorption.
Faucher C; Albert C; Beaufils H; Jouanneau C; Dupouet L
Nephrol Dial Transplant; 1997 May; 12(5):1037-9. PubMed ID: 9175066
[No Abstract] [Full Text] [Related]
16. Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy.
Nakamura T; Kawagoe Y; Ogawa H; Ueda Y; Hara M; Shimada N; Ebihara I; Koide H
Am J Kidney Dis; 2005 Jan; 45(1):48-53. PubMed ID: 15696443
[TBL] [Abstract][Full Text] [Related]
17. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K; Sakai S; Miyahara T
Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1153-60. PubMed ID: 3216557
[No Abstract] [Full Text] [Related]
18. Thirty years old lady with nephrotic syndrome: a case of biopsy proven lupus nephritis in Tanzania.
Fredrick F; Ruggajo PJ; Makanga G; Shija CK; Amdemariam M; Rugwizagonga B; Kitinya JN
Tanzan J Health Res; 2014 Apr; 16(2):127-30. PubMed ID: 26875307
[TBL] [Abstract][Full Text] [Related]
19. [Lupus nephritis with nephrotic syndrome successfully treated with plasmapheresis and cyclophosphamide].
Obroniecka I; Korsak J; Wańkowicz Z
Pol Arch Med Wewn; 1994 Mar; 91(3):227-31. PubMed ID: 8029131
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report.
Ideura T; Hora K; Kaneko Y; Yamazaki T; Tokunaga S; Shigematsu H; Kiyosawa K
Transplant Proc; 2000 Feb; 32(1):223-6. PubMed ID: 10701029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
